awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47145824-0B2FA45B-5CDB-42AF-929A-02AAC07B3C40
Q47145824-0B2FA45B-5CDB-42AF-929A-02AAC07B3C40
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47145824-0B2FA45B-5CDB-42AF-929A-02AAC07B3C40
Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk.
P2860
Q47145824-0B2FA45B-5CDB-42AF-929A-02AAC07B3C40
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47145824-0B2FA45B-5CDB-42AF-929A-02AAC07B3C40
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
96893b425e6125c2891d795d6df7865738577ce6
P2860
Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week res